No results for ‘’
Dishman Carbogen Amcis Ltd
₹167.25
(0.14%)
Sat, 19 Sept 2026, 01:27 pm
Health Technology
Pharmaceuticals: Major
24.5KDishman Carbogen Amcis Enterprise Value (EV)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 28.44 | 18.72 | 19.63 | 5.63 | 14.93 | 10.10 | 6.52 | 5.56 | 6.17 | 11.24 | 15.84 | 32.18 | 33.47 | 16.07 | 5.44 | 0 | 161.18 | 0 | 0 | 1050 |
| Price to book ratio | 6.95 | 4.81 | 4.01 | 1.16 | 2.19 | 0.94 | 0.40 | 0.54 | 0.57 | 1.09 | 1.87 | 0.97 | 1.01 | 0.63 | 0.15 | 0.30 | 0.52 | 0.34 | 0.66 | 0.59 |
| Price to sales ratio | 5.24 | 2.98 | 2.92 | 0.78 | 1.89 | 0.83 | 0.33 | 0.44 | 0.49 | 0.86 | 1.74 | 2.85 | 3.11 | 1.75 | 0.43 | 0.89 | 1.40 | 0.83 | 1.45 | 1.30 |
| Price to cash flow ratio | 89.86 | 59.44 | 123.27 | 9.58 | 6.65 | 5 | 4.05 | 7.51 | 2.42 | 6.26 | 12.77 | 17.75 | 26.98 | 14.07 | 1.58 | 3.41 | 9.01 | 12.02 | 12.61 | 15.06 |
| Enterprise value | 1635Cr | 2249Cr | 2967Cr | 1502Cr | 2456Cr | 1649Cr | 1196Cr | 1421Cr | 1519Cr | 2229Cr | 3596Cr | 5542Cr | 6106Cr | 4306Cr | 1953Cr | 2874Cr | 4266Cr | 3794Cr | 5568Cr | 5262Cr |
| Enterprise value to EBITDA ratio | 25.70 | 19.58 | 19.39 | 5.43 | 11.90 | 10.14 | 5.16 | 4.82 | 4.74 | 7.37 | 9.53 | 14.08 | 14.09 | 9.53 | 4.10 | 10.20 | 14.21 | 10.59 | 24.15 | 13.20 |
| Debt to equity ratio | 1.73 | 1.76 | 1.15 | 1.03 | 0.99 | 0.99 | 0.91 | 0.86 | 0.75 | 0.75 | 0.65 | 0.20 | 0.21 | 0.19 | 0.24 | 0.28 | 0.33 | 0.38 | 0.41 | 0.41 |
| Return on equity % | 30.30 | 36.19 | 26.86 | 22.90 | 15.77 | 9.62 | 6.27 | 10.23 | 9.90 | 9.92 | 12.73 | 4.64 | 3.12 | 4.01 | 2.86 | -2.89 | 0.32 | -0.52 | -2.68 | 0.06 |
Dishman Carbogen Amcis Ltd Enterprise Value
The Dishman Carbogen Amcis Ltd Enterprise Value is a key financial metric used by investors to evaluate Dishman Carbogen Amcis Ltd's valuation, profitability, and overall financial performance. Tracking the Dishman Carbogen Amcis Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Dishman Carbogen Amcis Ltd (NSE: DCAL, BSE: 540701) is currently trading at ₹167.25, with a market capitalization of ₹2622.98Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Dishman Carbogen Amcis Ltd Enterprise Value is essential for fundamental analysis.
Dishman Carbogen Amcis Ltd Enterprise Value Current Value
The current Dishman Carbogen Amcis Ltd Enterprise Value stands at 5262Cr.
The Dishman Carbogen Amcis Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Dishman Carbogen Amcis Ltd Enterprise Value Historical Trend
The Dishman Carbogen Amcis Ltd Enterprise Value has shown the following historical trend:
- 2024: 5262Cr
- 2023: 5568Cr
- 2022: 3794Cr
- 2021: 4266Cr
- 2020: 2874Cr
The decline in Dishman Carbogen Amcis Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Dishman Carbogen Amcis Ltd Enterprise Value Indicates for Investors
The Dishman Carbogen Amcis Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Dishman Carbogen Amcis Ltd.
Dishman Carbogen Amcis Ltd Enterprise Value Analysis Summary
The Dishman Carbogen Amcis Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Dishman Carbogen Amcis Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Dishman Carbogen Amcis Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.